| Azithromycin for prevention of exacerbations of COPD RK Albert, J Connett, WC Bailey, R Casaburi, JAD Cooper Jr, GJ Criner, ... New England Journal of Medicine 365 (8), 689-698, 2011 | 1201 | 2011 |
| Chronic obstructive pulmonary disease phenotypes: the future of COPD MLK Han, A Agusti, PM Calverley, BR Celli, G Criner, JL Curtis, LM Fabbri, ... American journal of respiratory and critical care medicine 182 (5), 598-604, 2010 | 1184 | 2010 |
| Analysis of the lung microbiome in the “healthy” smoker and in COPD JR Erb-Downward, DL Thompson, MK Han, CM Freeman, L McCloskey, ... PloS one 6 (2), e16384, 2011 | 765 | 2011 |
| Comparison of the respiratory microbiome in healthy nonsmokers and smokers A Morris, JM Beck, PD Schloss, TB Campbell, K Crothers, JL Curtis, ... American journal of respiratory and critical care medicine 187 (10), 1067-1075, 2013 | 521 | 2013 |
| Predictors of mortality in patients with emphysema and severe airflow obstruction FJ Martinez, G Foster, JL Curtis, G Criner, G Weinmann, A Fishman, ... American journal of respiratory and critical care medicine 173 (12), 1326-1334, 2006 | 478 | 2006 |
| Clinical significance of symptoms in smokers with preserved pulmonary function PG Woodruff, RG Barr, E Bleecker, SA Christenson, D Couper, JL Curtis, ... New England Journal of Medicine 374 (19), 1811-1821, 2016 | 400 | 2016 |
| Clinical significance of symptoms in smokers with preserved pulmonary function PG Woodruff, RG Barr, E Bleecker, SA Christenson, D Couper, JL Curtis, ... New England Journal of Medicine 374 (19), 1811-1821, 2016 | 400 | 2016 |
| Clinical significance of symptoms in smokers with preserved pulmonary function PG Woodruff, RG Barr, E Bleecker, SA Christenson, D Couper, JL Curtis, ... New England Journal of Medicine 374 (19), 1811-1821, 2016 | 400 | 2016 |
| Gender and chronic obstructive pulmonary disease: why it matters MLK Han, D Postma, DM Mannino, ND Giardino, S Buist, JL Curtis, ... American journal of respiratory and critical care medicine 176 (12), 1179-1184, 2007 | 384 | 2007 |
| Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes MLK Han, EA Kazerooni, DA Lynch, LX Liu, S Murray, JL Curtis, GJ Criner, ... Radiology 261 (1), 274-282, 2011 | 376 | 2011 |
| Pulmonary arterial enlargement and acute exacerbations of COPD JM Wells, GR Washko, MLK Han, N Abbas, H Nath, AJ Mamary, E Regan, ... New England Journal of Medicine 367 (10), 913-921, 2012 | 372 | 2012 |
| Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals CM Bassis, JR Erb-Downward, RP Dickson, CM Freeman, TM Schmidt, ... MBio 6 (2), 2015 | 360 | 2015 |
| The Usefulness of Induced Sputum in the Diagnosis of Pneumocystis carinii Pneumonia in Patients with the Acquired Immunodeficiency Syndrome TD Bigby, D Margolskee, JL Curtis, PF Michael, D Sheppard, WK Hadley, ... American Review of Respiratory Disease 133 (4), 515-518, 1986 | 340 | 1986 |
| Sex differences in severe pulmonary emphysema FJ Martinez, JL Curtis, F Sciurba, J Mumford, ND Giardino, G Weinmann, ... American journal of respiratory and critical care medicine 176 (3), 243-252, 2007 | 327 | 2007 |
| Simvastatin for the prevention of exacerbations in moderate-to-severe COPD GJ Criner, JE Connett, SD Aaron, RK Albert, WC Bailey, R Casaburi, ... New England Journal of Medicine 370 (23), 2201-2210, 2014 | 291 | 2014 |
| The immunopathogenesis of chronic obstructive pulmonary disease: insights from recent research JL Curtis, CM Freeman, JC Hogg Proceedings of the American Thoracic Society 4 (7), 512-521, 2007 | 277 | 2007 |
| Clinical and radiologic disease in smokers with normal spirometry EA Regan, DA Lynch, D Curran-Everett, JL Curtis, JHM Austin, ... JAMA internal medicine 175 (9), 1539-1549, 2015 | 240 | 2015 |
| Spatial variation in the healthy human lung microbiome and the adapted island model of lung biogeography RP Dickson, JR Erb-Downward, CM Freeman, L McCloskey, JM Beck, ... Annals of the American Thoracic Society 12 (6), 821-830, 2015 | 228 | 2015 |
| Design of the subpopulations and intermediate outcomes in COPD study (SPIROMICS) D Couper, LM LaVange, ML Han, RG Barr, E Bleecker, EA Hoffman, ... Thorax 69 (5), 492-495, 2014 | 216 | 2014 |
| Significance of the microbiome in obstructive lung disease MLK Han, YJ Huang, JJ LiPuma, HA Boushey, RC Boucher, WO Cookson, ... Thorax 67 (5), 456-463, 2012 | 212 | 2012 |
Fernando Martinezprofessor of medicine, weill cornellEmail verificata su med.cornell.edu
